• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者尿 Smad1 水平与肾小球高滤过的相关性。

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.

机构信息

Department of Laboratory, Affiliated Houjie Hospital, Guangdong Medical College, 523945, Dongguan, China.

出版信息

Endocrine. 2013 Apr;43(2):346-50. doi: 10.1007/s12020-012-9741-9. Epub 2012 Jul 14.

DOI:10.1007/s12020-012-9741-9
PMID:22798249
Abstract

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration (GHF) in type 2 diabetes mellitus (T2DM), and to explore the factors related to the urinary Smad1 in T2DM. The reference value of the estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals. 30 patients with GHF, 58 patients with norm-GFR T2DM, and 24 healthy patients who served as controls were recruited. Urinary Smad1, fasting plasma glucose (FPG), fasting serum C-Peptide (C-P), hemoglobin A1C (HbA1c), cystatin C, and other chemistry laboratory parameters of T2DM participants and controls were measured. Patients with GHF had higher levels of urinary Smad1 than the control group, and those with norm-GFR. For T2DM patients with body mass index, age, and gender adjustments, urinary Smad1 was positively correlated with FPG, HbA1C, and eGFR, but negatively correlated with fasting serum C-P. Multivariate linear regression analysis demonstrated that eGFR, HbA1C, and fasting serum C-P were independently associated with urinary Smad1. High levels of urinary Smad1 were found in GHF patients with T2DM, which may be another potential mechanism of GHF in relation to diabetic nephropathy.

摘要

本研究旨在评估 2 型糖尿病(T2DM)患者尿液 Smad1 与肾小球高滤过(GHF)之间的关系,并探讨 T2DM 患者尿液 Smad1 相关的因素。在 248 名健康个体中确定了估算肾小球滤过率(eGFR)的参考值。招募了 30 名 GHF 患者、58 名 norm-GFR T2DM 患者和 24 名健康对照者。测量了 T2DM 患者和对照组的尿液 Smad1、空腹血糖(FPG)、空腹血清 C-肽(C-P)、糖化血红蛋白(HbA1c)、胱抑素 C 和其他化学实验室参数。GHF 患者的尿液 Smad1 水平高于对照组和 norm-GFR 患者。对 T2DM 患者的体重指数、年龄和性别进行调整后,尿液 Smad1 与 FPG、HbA1c 和 eGFR 呈正相关,与空腹血清 C-P 呈负相关。多元线性回归分析表明,eGFR、HbA1c 和空腹血清 C-P 与尿液 Smad1 独立相关。在患有 T2DM 的 GHF 患者中发现了高水平的尿液 Smad1,这可能是 GHF 与糖尿病肾病相关的另一个潜在机制。

相似文献

1
Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.2 型糖尿病患者尿 Smad1 水平与肾小球高滤过的相关性。
Endocrine. 2013 Apr;43(2):346-50. doi: 10.1007/s12020-012-9741-9. Epub 2012 Jul 14.
2
Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.2 型糖尿病伴肾小球高滤过患者管状标记物的变化。
Diabetes Res Clin Pract. 2012 Jan;95(1):105-9. doi: 10.1016/j.diabres.2011.09.031. Epub 2011 Oct 20.
3
Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy.尿Smad3升高与肾小球高滤过及肾小球滤过率降低显著相关,是糖尿病肾病一种新的尿液生物标志物。
BMC Nephrol. 2015 Oct 8;16:159. doi: 10.1186/s12882-015-0156-8.
4
Fluctuation between fasting and 2-H postload glucose state is associated with glomerular hyperfiltration in newly diagnosed diabetes patients with HbA1c < 7%.空腹血糖与负荷后2小时血糖状态之间的波动,与新诊断的糖化血红蛋白(HbA1c)<7%的糖尿病患者的肾小球高滤过有关。
PLoS One. 2014 Oct 31;9(10):e111173. doi: 10.1371/journal.pone.0111173. eCollection 2014.
5
Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32).胱抑素C和胱抑素肾小球滤过率作为亚洲印度糖耐量异常受试者早期肾病标志物(CURES-32研究)
Metab Syndr Relat Disord. 2009 Oct;7(5):419-25. doi: 10.1089/met.2008.0084.
6
Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.血糖控制不佳和肾功能下降与 2 型糖尿病患者肾内 RAS 活性增加有关。
Diabetes Res Clin Pract. 2014 Jul;105(1):40-6. doi: 10.1016/j.diabres.2014.04.019. Epub 2014 Apr 28.
7
Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.就诊间血糖过度变异性会独立加剧2型糖尿病患者内皮功能和肾功能障碍的进展。
BMC Nephrol. 2016 Jul 7;17(1):67. doi: 10.1186/s12882-016-0300-0.
8
Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region.在非洲地区的人群中,2 型糖尿病或空腹血糖受损的受试者存在肾小球高滤过和近端钠重吸收增加。
Nephrol Dial Transplant. 2010 Jul;25(7):2225-31. doi: 10.1093/ndt/gfq008. Epub 2010 Feb 1.
9
Postprandial glycemic control conditions in relation to urinary N-acetyl-β-D-glucosaminidase in patients with type 2 diabetes mellitus without low glomerular filtration rate.2型糖尿病且肾小球滤过率正常患者的餐后血糖控制状况与尿N-乙酰-β-D-氨基葡萄糖苷酶的关系
Diabetes Technol Ther. 2014 Jan;16(1):41-7. doi: 10.1089/dia.2013.0155. Epub 2013 Oct 10.
10
Glycemia affects glomerular filtration rate in people with type 2 diabetes.血糖会影响 2 型糖尿病患者的肾小球滤过率。
BMC Nephrol. 2019 Oct 29;20(1):397. doi: 10.1186/s12882-019-1584-7.

引用本文的文献

1
Early renal structural changes and potential biomarkers in diabetic nephropathy.糖尿病肾病的早期肾脏结构变化及潜在生物标志物
Front Physiol. 2022 Nov 8;13:1020443. doi: 10.3389/fphys.2022.1020443. eCollection 2022.
2
The Role of Bone Morphogenetic Proteins in Diabetic Complications.骨形态发生蛋白在糖尿病并发症中的作用。
ACS Pharmacol Transl Sci. 2019 Oct 29;3(1):11-20. doi: 10.1021/acsptsci.9b00064. eCollection 2020 Feb 14.
3
Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy.

本文引用的文献

1
Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.2 型糖尿病伴肾小球高滤过患者管状标记物的变化。
Diabetes Res Clin Pract. 2012 Jan;95(1):105-9. doi: 10.1016/j.diabres.2011.09.031. Epub 2011 Oct 20.
2
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.短期 2 型糖尿病患者的尿肾小管标志物:一项横断面研究。
Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.
3
Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis.
尿Smad3升高与肾小球高滤过及肾小球滤过率降低显著相关,是糖尿病肾病一种新的尿液生物标志物。
BMC Nephrol. 2015 Oct 8;16:159. doi: 10.1186/s12882-015-0156-8.
4
New insights into molecular mechanisms of diabetic kidney disease.糖尿病肾病分子机制的新见解。
Am J Kidney Dis. 2014 Feb;63(2 Suppl 2):S63-83. doi: 10.1053/j.ajkd.2013.10.047.
5
Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.尿Smad1是诊断和评估糖尿病肾病严重程度的一种新生物标志物。
Endocrine. 2014 May;46(1):83-9. doi: 10.1007/s12020-013-0033-9. Epub 2013 Aug 13.
转化生长因子-β1 T869C 多态性与糖尿病肾病的关系:一项荟萃分析。
Endocrine. 2011 Dec;40(3):372-8. doi: 10.1007/s12020-011-9503-0. Epub 2011 Jul 2.
4
Smad1 plays an essential role in bone development and postnatal bone formation.Smad1 在骨骼发育和出生后骨形成中发挥着重要作用。
Osteoarthritis Cartilage. 2011 Jun;19(6):751-62. doi: 10.1016/j.joca.2011.03.004. Epub 2011 Mar 21.
5
Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.Smad1 在糖尿病肾病中的作用:分子机制及其作为诊断标志物的意义。
Histol Histopathol. 2011 Apr;26(4):531-41. doi: 10.14670/HH-26.531.
6
C-peptide as a therapeutic tool in diabetic nephropathy.C 肽在糖尿病肾病中的治疗作用。
Am J Nephrol. 2010;31(5):389-97. doi: 10.1159/000289864. Epub 2010 Mar 31.
7
Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.尿 L-FABP 与贫血:尿标志物在 2 型糖尿病中的不同作用。
Eur J Clin Invest. 2010 Feb;40(2):95-102. doi: 10.1111/j.1365-2362.2009.02220.x. Epub 2009 Nov 11.
8
Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes.1型糖尿病中的肾脏高滤过与微量白蛋白尿的发生
Diabetes Care. 2009 May;32(5):889-93. doi: 10.2337/dc08-1560. Epub 2009 Feb 5.
9
C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy.C肽逆转转化生长因子-β1诱导的肾近端小管细胞变化:对糖尿病肾病治疗的意义。
Am J Physiol Renal Physiol. 2009 Mar;296(3):F614-21. doi: 10.1152/ajprenal.90500.2008. Epub 2008 Dec 17.
10
Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.在超滤与肾功能损害之间:揭开糖尿病肾病早期肾功能变化的神秘面纱。
Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S46-53. doi: 10.1016/j.diabres.2008.09.018. Epub 2008 Oct 11.